 |
|
Phase II Trial of Irinotecan plus Cisplatin Combination as First Line Therapy for Patients with Small cell Lung Cancer.
Hye Cheol Jeong, Sang Yeub Lee, Jung Ha Kim, Eun Sil Ha, Jin Yong Jung, Kyung Ju Lee, Seung Hyeun Lee, Se Joong Kim, Eun Joo Lee, Gyu Young Hur, Sung Yong Lee, Je Hyeong Kim, Chol Shin, Jae Jeong Shim, Kwang Ho In, Kyung Ho Kang, Se Hwa Yoo
Tuberc Respir Dis. 2006;60(1):57-64. Published online 2006 Jan 1 DOI: https://doi.org/10.4046/trd.2006.60.1.57
|
|
Citations to this article as recorded by
 Phase II Study of Irinotecan Plus Cisplatin as First Line therapy in Extensive Small-Cell Lung Cancer
Ki Eun Hwang, So Young Kim, Jong Hoon Jung, Seong Hoon Park, Jung Hyun Park, Hwi Jung Kim, Hak Ryul Kim, Sei Hoon Yang, Eun Taik Jeong
Tuberculosis and Respiratory Diseases.2006; 61(2): 143. CrossRef
|